Evolution and natural history of chronic lung disease of prematurity

A R Hulsmann1, J N van den Anker

  • 1Dept of Pediatrics, Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Chronic lung disease (CLD) in premature infants results from respiratory distress syndrome (RDS) treatment. Pulmonary inflammation and fibrosis characterize CLD, leading to long-term respiratory and growth issues in survivors.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Chronic lung disease (CLD) of prematurity is a significant complication in preterm infants treated for respiratory distress syndrome (RDS).
  • Key risk factors include premature birth, mechanical ventilation, and supplemental oxygen therapy.
  • Pulmonary inflammation is increasingly recognized as a central factor in CLD pathogenesis.

Purpose of the Study:

  • To describe the pathological evolution and clinical manifestations of CLD in preterm infants.
  • To highlight the distinct phases of CLD: inflammatory, subacute fibroproliferative, and chronic fibroproliferative.
  • To examine the long-term pulmonary function outcomes and associated complications in survivors.

Main Methods:

  • The study reviews histological findings and clinical observations of CLD development.
  • It describes the progression from initial lung injury to chronic airway remodeling.
  • Analysis includes bronchoalveolar lavage findings and pathological lung examination.

Main Results:

  • The early phase shows inflammation, hyaline membranes, and epithelial necrosis, clinically resembling RDS.
  • The subacute phase is marked by hyperplasia, smooth muscle hypertrophy, and interstitial fibrosis.
  • The chronic phase involves airway remodeling, persistent respiratory distress, hypoxia, and potential pulmonary hypertension.

Conclusions:

  • CLD progresses through distinct inflammatory and fibroproliferative stages with evolving pathology.
  • Survivors often exhibit persistent lung function abnormalities, including increased airway resistance and air trapping.
  • Long-term pulmonary function and potential age-related changes in adults who had CLD warrant further investigation.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...